4
Changes in Ownership
Seres Therapeutics, Inc. Filed Acc 0000950170-25-017910
Options or other derivatives
- Chief Legal Officer and EVP acquired 650,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
DesRosier Thomas · Chief Legal Officer and EVP
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-02-07 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +650,000 | 650,000 | D |
Loading xslF345X05/ownership.xml…